141 related articles for article (PubMed ID: 33485810)
1. Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer.
Barnes EA; Martell K; Parra-Herran C; Taggar AS; Donovan E; Leung E
Brachytherapy; 2021; 20(3):527-535. PubMed ID: 33485810
[TBL] [Abstract][Full Text] [Related]
2. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
[TBL] [Abstract][Full Text] [Related]
3. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
[TBL] [Abstract][Full Text] [Related]
4. Is Substantial Lymphovascular Space Invasion Prognostic in Patients With Pathologically Lymph Node-Negative Endometrial Cancer?
Pifer PM; Jaishankar S; Bhargava R; Schad MD; Keller A; Musunuru HB; Cohen M; Sukumvanich P; Courtney-Brooks M; Boisen M; Berger JL; Olawaiye A; Lesnock J; Edwards R; Taylor S; Vargo JA; Beriwal S
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):148-153. PubMed ID: 36893818
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Beavis AL; Yen TT; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan AN; Jager LR; Fader AN
Gynecol Oncol; 2020 Mar; 156(3):568-574. PubMed ID: 31948730
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.
Weinberg LE; Kunos CA; Zanotti KM
Int J Gynecol Cancer; 2013 Oct; 23(8):1438-45. PubMed ID: 24257558
[TBL] [Abstract][Full Text] [Related]
7. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
8. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
Peters EEM; Léon-Castillo A; Hogdall E; Boennelycke M; Smit VTHBM; Hogdall C; Creutzberg CL; Bosse T; Nout RA; Ørtoft G
Int J Gynecol Pathol; 2022 May; 41(3):227-234. PubMed ID: 34392268
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Lymphovascular Space Invasion in the Absence of Lymph Node Metastases in Early-Stage Endometrial Cancer.
Cusano E; Myers V; Samant R; Sudai T; Keller A; Le T; E C; Grimes S; Xu Y
Int J Gynecol Cancer; 2018 Jun; 28(5):890-894. PubMed ID: 29538248
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
13. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Adjuvant Cylinder Brachytherapy for Endometrioid Endometrial Cancer.
Alban GM; Buscariollo DL; Cheng T; Pretz J; Krechmer B; Buzurovic I; Singer L; King M; Lee L
Pract Radiat Oncol; 2020; 10(2):95-103. PubMed ID: 31783169
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center.
Dai Y; Dong Y; Cheng Y; Hou H; Wang J; Wang Z; Wang J
J Gynecol Oncol; 2020 May; 31(3):e27. PubMed ID: 31912681
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
17. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use.
Boothe D; Wolfson A; Christensen M; Francis S; Werner TL; Gaffney DK
Am J Clin Oncol; 2019 Jul; 42(7):549-554. PubMed ID: 31169554
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
[TBL] [Abstract][Full Text] [Related]
20. Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer.
Tortorella L; Restaino S; Zannoni GF; Vizzielli G; Chiantera V; Cappuccio S; Gioè A; La Fera E; Dinoi G; Angelico G; Scambia G; Fanfani F
J Gynecol Oncol; 2021 Mar; 32(2):e11. PubMed ID: 33470061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
